Drug release from HPMC matrices in milk and fat-rich emulsions

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 4823-4835

  Williams, Hywel D ^a,e   Nott, Kevin P ^b   Barrett, David A ^a   Ward, Rob ^c   Hardy, Ian J ^d   Melia, Colin D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b OXFORD INSTRUMENTS PLASMA TECHNOLOGY   (United Kingdom)

^c MSD Development Laboratories   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Controlled release; Dissolution rate; Excipients; Imaging methods food effects; Solid dosage form; Tablet

Indexed keywords

FLUORESCEIN; HYDROXYPROPYLMETHYLCELLULOSE; INTRALIPID;

ARTICLE; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; DRUG RELEASE; HYDRODYNAMICS; LIPID STORAGE; MILK; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE SEPARATION; TABLET;

EID: 80053230717     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22689     Document Type: Article

References (45)

1. Melia CD. 1991. Hydrophilic matrix sustained release systems based on polysaccharide carriers. Crit Rev Ther Drug Carrier Syst 08:395-421.
2. Li CL, Martini LG, Ford JL, Roberts M. 2005. The use of hypromellose in oral drug delivery. J Pharm Pharmacol 57:533-546.
3. Colombo P. 1993. Swelling-controlled release in hydrogel matrices for oral route. Adv Drug Deliv Rev 11:37-57.
4. McInnes F, Clear N, Humphrey M, Stevens HN. 2008. In vivo performance of an oral MR matrix tablet formulation in the beagle dog in the fed and fasted state: Assessment of mechanical weakness. Pharm Res 25:1075-1084.
5. Abrahamsson B, Alpsten M, Bake B, Jonsson UE, Eriksson-Lepkowska M, Larsson A. 1998. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J Control Release 52:301-310.
6. Davis J, Burton J, Connor AL, Macrae R, Wilding IR. 2009. Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294, 315. J Pharm Sci 98:1568-1576.
7. Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH. 2002. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: Pronounced lag-time after a high fat breakfast. Br J Clin Pharmacol 53:582-588.
8. Lukkari E, CastrenKortekangas P, Juhakoski A, Loyttyniemi E, Aranko K, Neuvonen PJ. 1996. Effect of food on the bioavailability of oxybutynin from a controlled release tablet. Eur J Clin Pharmacol 50:221-223.
9. Ghimire M, Hodges LA, Band J, O'Mahony B, McInnes FJ, Mullen AB, Stevens HNE. 2010. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets. J Control Release 147:70-75.
10. Liu SQ, Joshi SC, Lam YC. 2008. Effects of salts in the Hofmeister series and solvent isotopes on the gelation mechanisms for hydroxypropylmethylcellulose hydrogels. J Appl Polym Sci 109:363-372.
11. Pygall SR, Kujawinski S, Timmins P, Melia CD. 2009. Mechanisms of drug release in citrate buffered HPMC matrices. Int J Pharm 370:110-120.
12. Williams HD, Ward R, Hardy IJ, Melia CD. 2009. The extended release properties of HPMC matrices in the presence of dietary sugars. J Control Release 138:251-259.
13. Williams HD, Ward R, Hardy IJ, Melia CD. 2010. The effect of sucrose and salts in combination on the drug release behaviour of an HPMC matrix. Eur J Pharm Biopharm 76:433-436.
14. Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG, Crowley PJ. 2007. Influence of ethanol on aspirin release from hypromellose matrices. Int J Pharm 332:31-37.
15. Mitchell K, Ford JL, Armstrong DJ, Elliott PNC, Rostron C, Hogan JE. 1990. The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrix tablets. Int J Pharm 66:233-242.
16. Richardson JC, Foster CS, Doughty SW, Burton JS, MacRae RJ, Melia CD. 2006. The influence of L-amino acid molecular structure on the phase transition temperature of hydroxypropyl methylcellulose. Carbohydr Polymers 65:22-27.
17. Maturu PK, Prasad VK, Worsley WN, Shiu GK, Skelly JP. 1986. Influence of a high-fat breakfast on the bioavailability of theophylline controlled-release formulations-An in vitro demonstration of an in vivo observation. J Pharm Sci 75:1205-1206.
18. Macheras P, Koupparis M, Tsaprounis C. 1986. Drug dissolution studies in milk using the automated flow-injection serial dynamic dialysis technique. Int J Pharm 33:125-136.
19. Macheras P, Koupparis M, Apostolelli E. 1987. Dissolution of 4 controlled-release theophylline formulations in milk. Int J Pharm 36:73-79.
20. Diakidou A, Vertzoni M, Abrahamsson B, Dressman J, Reppas C. 2009. Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach. Eur J Pharm Sci 37:133-140.
21. Abrahamsson B, Albery T, Eriksson A, Gustafsson I, Sjoberg M. 2004. Food effects on tablet disintegration. Eur J Pharm Sci 22:165-172.
22. Ashby LJ, Beezer AE, Buckton G. 1989. In vitro dissolution testing of oral controlled release preparations in the presence of artificial foodstuffs.1. Exploration of alternative methodology-Microcalorimetry. Int J Pharm 51:245-251.
23. Rotenberg M, Rubin M, Bor A, Meyuhas D, Talmon Y, Lichtenberg D. 1991. Physicochemical characterization of intralipid emulsions. Biochim Biophys Acta 1086:265-272.
24. Timmermans J, Moes AJ. 1990. How well do floating dosage forms float. Int J Pharm 62:207-216.
25. CDER. 2002. Guidance for industry: Food-effect bioavailability and fed bioequivalence studies. Food and Drug Administration, Rockville.
26. Karim A, Burns T, Janky D, Hurwitz A. 1985. Food-induced changes in theophylline absorption from controlled-release formulations.2. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption. Clin Pharmacol Ther 38:642-647.
27. Armstrong J, Challenor VF, Macklin BS, Renwick AG, Waller DG. 1997. The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard). Eur J Clin Pharmacol 53:141-143.
28. Fabre LF, Timmer CJ. 2003. Effects of food on the bioavailability of gepirone from extended-release tablets in humans: Results of two open-label crossover studies. Curr Ther Res Clin Exp 64:580-598.
29. Williams HD, Anna C, Ward R, Hardy IJ, Melia CD. 2010. Designing HPMC matrices with improved resistance to sugar. Int J Pharm 401:51-59.
30. Williams HD, Barrett DA, Ward R, Hardy IJ, Melia CD. 2010. A liquid chromatography method for quantifying caffeine dissolution from pharmaceutical formulations into colloidal, fat-rich media. J Chromatogr B-Anal Technol Biomed Life Sci 878:1739-1745.
31. Ford JL, Rubinstein MH, McCaul F, Hogan JE, Edgar PJ. 1987. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int J Pharm 40:223-234.
32. British Medical Association and the Royal Pharmaceutical Society of Great Britain. 2009. British National Formulary. London: BMA and RPSGB.
33. Bajwa GS, Hoebler K, Sammon C, Timmins P, Melia CD. 2006. Microstructural imaging of early gel layer formation in HPMC matrices. J Pharm Sci 95:2145-2157.
34. Nott KP. 2010. Magnetic resonance imaging of tablet dissolution. Eur J Pharm Biopharm 74:78-83.
35. The United States Pharmacopoeia. 2006. The National Formulary. Rockville: United States Pharmacopeial Convention, Inc.
36. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157.
37. Feldman M, Barnett C. 1995. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterol 108:125-131.
38. Williams HD. 2009. Exploring the mechanisms of direct food-effects on HPMC behaviour: Formulation Insights. Nottingham: University of Nottingham, pp 290.
39. Parojcic J, Vasiljevic D, Ibric S, Djuric Z. 2008. Tablet disintegration and drug dissolution in viscous media: Paracetamol IR tablets. Int J Pharm 355:93-99.
40. Pygall SR, Kujawinski S, Timmins P, Melia CD. 2010. The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug. Int J Pharm 387:93-102.
41. Karoui R, Dufour E. 2003. Dynamic testing rheology and fluorescence spectroscopy investigations of surface to centre differences in ripened soft cheeses. Int Dairy J 13:973-985.
42. Dufour E, Riaublanc A. 1997. Potentiality of spectroscopic methods for the characterisation of dairy products. I. Front-face fluorescence study of raw. Heated and Homogenised Milks Lait 77:657-670.
43. Metz H, Mader K. 2008. Benchtop-NMR and MRI-A new analytical tool in drug delivery research. Int J Pharm 364:170-175.
44. Mariette F. 2009. Investigations of food colloids by NMR and MRI. Curr Opin Colloid Interface Sci 14:203-211.
45. Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli ME, Peppas NA, Manna AL. 1990. Drug release modulation by physical restrictions of matrix swelling. Int J Pharm 63:43-48.